Integrated spatial and single-cell transcriptomics reveals RPL8 as a prognostic biomarker and therapeutic target in hepatocellular carcinoma
RPL8 drives HCC progression and immune evasion, qualifying it as a diagnostic biomarker and therapeutic target.
Authors
- Hui Yin (ORCID: https://orcid.org/0000-0002-1590-4075)
- Jinna Michelle Tan
- Fu Long
- Jiaqian He
- Hongsheng Lin
- Yuzhen Luo
- Mingfen Li
- Hemeng Wu
- Yaoyang Li
- Junzhu Liang
Institutions
- Guangxi University (CN)
- The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine (CN)
- Guangxi University of Chinese Medicine (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1016/j.tranon.2025.102663
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00